Skip to main content
. 2019 Sep 16;60(10):898–904. doi: 10.3349/ymj.2019.60.10.898

Table 1. Baseline Characteristics of Patients according to Expression Status Related to Shh Pathway.

Variables Patient number (%) Shh p value Gli1 p value Patched p value Smo p value
Yes (n=5) No (n=31) Yes (n=12) No (n=24) Yes (n=5) No (n=31) Yes (n=6) No (n=30)
Median age in years (range) 65 (49–75) 65 (49–75) 66 (50–75) 0.810 66 (50–75) 65 (49–75) 0.797 65 (51–68) 67 (49–75) 0.431 61 (57–68) 67 (49–75) 0.587
Sex 0.084 0.588 0.084 0.535
 Male 32 (88.9) 3 (60.0) 29 (93.5) 10 (83.3) 22 (91.7) 3 (60.0) 29 (93.5) 5 (83.3) 27 (90.0)
 Female 4 (11.1) 2 (40.0) 2 (6.5) 2 (16.7) 2 (8.3) 2 (40.0) 2 (6.5) 1 (16.7) 3 (10.0)
ECOG 0.571 0.655 >0.999 0.655
 0 10 (27.8) 1 (20.0) 9 (29.0) 4 (33.3) 6 (25.0) 1 (20.0) 9 (29.0) 1 (16.7) 9 (30.0)
 ≥1 26 (72.2) 4 (80.0) 22 (71.0) 8 (66.7) 18 (75.0) 4 (80.0) 22 (71.0) 5 (83.3) 21 (70.0)
Metastasis
 Brain 7 (20.0) 1 (20.0) 6 (19.4) >0.999 0 (0.0) 7 (29.2) 0.072 1 (20.0) 6 (19.4) >0.999 0 (0.0) 7 (23.3) 0.311
 Liver 9 (25.7) 2 (40.0) 7 (22.6) 0.586 3 (25.0) 6 (25.0) >0.999 4 (80.0) 5 (16.1) 0.010 2 (33.3) 7 (23.3) 0.635
 Lung 8 (22.9) 0 (0.0) 8 (25.8) 0.315 3 (25.0) 5 (20.8) 0.685 0 (0.0) 8 (25.8) 0.315 2 (33.3) 6 (20.0) 0.602
 Bone 13 (37.1) 3 (60.0) 10 (32.3) 0.337 4 (33.3) 9 (37.5) >0.999 4 (80.0) 9 (29.0) 0.052 3 (50.0) 10 (33.3) 0.648
 P.E. 15 (42.9) 2 (40.0) 13 (41.9) >0.999 6 (50.0) 9 (37.5) 0.467 0 (0.0) 15 (48.4) 0.057 4 (66.7) 11 (36.7) 0.367
 P.C.E. 3 (8.6) 0 (0.0) 3 (9.7) >0.999 1 (8.3) 2 (8.3) >0.999 0 (0.0) 3 (9.7) >0.999 0 (0.0) 3 (10.0) >0.999

Shh, sonic hedgehog; Gli1, glioma-associated oncogene homolog zinc finger protein 1; Smo, Ptch-mediated repression of smoothened; ECOG, Eastern Cooperative Oncology Group; P.E., pleural effusion; P.C.E., pericardial effusion.

Values are presented as median (range) or n (%) unless otherwise indicated.